Navigation Links
Shark Branding Corp. CEO Daymond John and Fuse Science CEO Brian Tuffin to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox"

MIAMI LAKES, Fla., March 1, 2013 /PRNewswire/ -- Fuse Science, Inc. (OTCQB: DROP), ( a consumer products and delivery technology company that is developing new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals is pleased to announce that CEO Brian Tuffin and Daymond John , CEO of Shark Branding, LLC and Shark Branding Corp. are scheduled to be interviewed on Bloomberg Television's "Taking Stock with Pimm Fox" today, March 1st, 2013."Taking Stock", hosted by Bloomberg Television anchor Pimm Fox, offers insight into company news, long-term strategy, trading tactics, market techniques, stocks, bonds, commodities and currencies and is broadcast weekdays at 5:00 pm EST.

A replay of the interview will be archived and available within the Investor Relations section of the Fuse Science, Inc. corporate web site: shortly after the broadcast.About Shark Branding Corp.Shark Branding's team of expert communicators, strategic analysts, and creative heavyweights excels in transforming businesses into iconic brands.  At the helm is business and branding expert Daymond John , CEO and Founder of FUBU, a $6 billion global fashion game-changer.  Daymond's entrepreneurialism and trend-moving influence are key to the company's cultivation of great brands.  Putting products in the hands of influencers and trendsetters is Shark Branding's core practice. Shark Branding clients benefit from a 360 degree approach to the growth of a healthy, successful brand with services ranging from brand strategy, design, and licensing; event development; celebrity affiliation and media; digital marketing; and the fundamentals of business leadership.  For more information, visit:

About Fuse Science, Inc.Fuse Science, Inc. (OTCQB: DROP), is an innovative consumer products holding company based in Miami Lakes, Florida.  Fuse Science holds the rights to new, patent-pending technologies poised to redefine how consumers receive energy, medicines, vitamins and minerals.  The company maintains the rights to sublingual and transdermal delivery systems for bioactive agents that can now, for the first time, effectively encapsulate and charge many varying molecules in order to produce complete product formulations which can bypass the gastrointestinal tract and enter the blood stream directly - all in a concentrated "DROP" form that is simply applied under the tongue.  The Fuse Science technology is designed to accelerate conveyance of medicines or nutrients relative to traditional pills and liquids and can enhance how consumers receive these products.  Information about Fuse Science is available online at and or by calling 305-503-FUSE (3873).

For Fuse news as it happens, follow @Fuse_Science on Twitter and Like Us on Facebook HERE!For more information:To schedule an interview:Fuse Science, Inc.Gus DeQuesadaInvestor RelationsMichelsen AdvertisingDirect: (305) 503-3873, Ext. 2C-305-733-1410 / 786-488-7138Email:

prnews@michelsenadvertising.comSafe Harbor StatementCertain statements and information included in this release may constitute "forward-looking statements" as defined in the Federal Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied in such statements. Additional discussion of factors that could cause actual results to differ materially from management's projections, estimates and expectations is contained in the Company's SEC filings. The Company assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by federal securities laws.

SOURCE Fuse Science, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Synteract Unveils New Branding at DIA 2012 to Support Enhanced Commercial Strategy
2. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
3. BioSpecifics Technologies Corp. Announces Appointment of George Gould to Board of Directors
4. BioSpecifics Technologies Corp. Announces Presentations at Two Upcoming Investor Conferences in March
5. Trovagene, Inc. Announces Full Exercise of Over-Allotment Option by Aegis Capital Corp.
6. BioSpecifics Technologies Corp. Reports Second Quarter 2012 Financial Results
7. BioSpecifics Technologies Corp. To Present at UBS Global Life Sciences Conference
8. BioSpecifics Technologies Corp. Reports Third Quarter 2012 Financial Results
9. BioSpecifics Technologies Corp. Investor Presentation Now Available for On-demand Viewing at
10. Free Research Report on Dyax Corp., Ebix, Inc., 8x8, Inc., EnerSys and Express Scripts Holding Co.
11. Tonicology LLC Partners with Taiwan's CGB, Corp. to Offer Pure Extracts of Rare Herbal Supplements
Post Your Comments:
(Date:11/27/2015)... 2015 --> ... companion diagnostics is one of the major ... pharmaceutical companies and diagnostic manufacturers working together ... . --> ... global cancer biomarkers market spread across 89 ...
(Date:11/25/2015)...  PharmAthene, Inc. (NYSE MKT: PIP) announced  today that ... plan (Rights Plan) in an effort to preserve the ... Section 382 of the Internal Revenue Code (Code). ... of its NOLs could be substantially limited if the ... 382 of the Code. In general, an ownership change ...
(Date:11/25/2015)... Nov. 25, 2015  Neurocrine Biosciences, Inc. (Nasdaq: ... President and CEO of Neurocrine Biosciences, will be presenting ... New York . ... website approximately 5 minutes prior to the presentation to ... the presentation will be available on the website approximately ...
(Date:11/25/2015)... November 25, 2015 The ... is a professional and in-depth study on the ...      (Logo: ) , ... industry including definitions, classifications, applications and industry chain ... the international markets including development trends, competitive landscape ...
Breaking Biology Technology:
(Date:11/16/2015)... Calif. , Nov 16, 2015  Synaptics ... of human interface solutions, today announced expansion of ... TouchView ™ touch controller and display driver ... revolution of smartphones. These new TDDI products add ... TD4100 (HD resolution), TD4302 (WQHD resolution), and TD4322 ...
(Date:11/10/2015)... , Nov. 10, 2015  In this ... the basis of product, type, application, disease ... in this report are consumables, services, software. ... are safety biomarkers, efficacy biomarkers, and validation ... report are diagnostics development, drug discovery and ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
Breaking Biology News(10 mins):